Essex Bio-Technology sets 5 Aug 2026 board meeting to approve H1 2026 results and consider interim dividend

Bulletin Express07-24

Essex Bio-Technology Limited has issued a notice convening a board meeting for 4:00 p.m. on Wednesday, 5 August 2026, at Room 3206, West Tower, Shun Tak Centre, 168-200 Connaught Road Central, Hong Kong.

The agenda includes: 1. Reviewing and approving the interim financial results for the six months ended 30 June 2026. 2. Deliberating on the declaration and amount of any interim dividend.

The notice is signed by Director Fang Haizhou on behalf of the board. As of the announcement date (24 July 2026), the board comprises four executive directors—Ngiam Mia Je Patrick, Fang Haizhou, Ngiam Hian Leng Malcolm and Yau Lai Man—and three independent non-executive directors—Fung Chi Ying, Yeow Mee Mooi and Yan Man Sing Frankie.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment